Prunella vulgaris Polysaccharide Inhibits Growth and Migration of Breast Carcinoma-Associated Fibrob

来源 :中国结合医学杂志(英文版) | 被引量 : 0次 | 上传用户:yh124712
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To study the effects of Prunella vulgaris polysaccharide (PVP) on human breast carcinoma-associated fibroblasts (CAFs).Method:Cell viability was detected by 3-[4,5-dimethylthiazol-2-yl]-2,5-(3-carboxymethoxyphenyl)-2-4-sulfophenyl)-2H-tetrazolium (MTS) assay.Wound healing experiment and transwell migration assay were used to investigate the anti-migration effects.Flow cytometry was applied to detect cell apoptosis and cell cycle distribution.Reverse transcription-polymerase chain reaction and enzyme-linked immunosorbentassay were used to detect the expression of basic fibroblast growth factor (bFGF) in CAFs.Culture SKBr-3 with CAFs conditioned medium (CAFs-CM) to evaluate the indirect function on the proliferation of breast cancer SKBr-3 cells.Results:PVP inhibited the viability of CAFs by inducing apoptosis (P<0.01) and arresting cell cycle (P<0.01).It also inhibited the migration of CAFs (P<0.01).bFGF promoted CAFs proliferation (P<0.01) and migration (P<0.01),protected CAFs from apoptosis (P<0.05) and reduced G0 phase to 49.06% (P<0.01).However,these effects of bFGF on CAFs could be abrogated by PVP.Culturing SKBr-3 with CAFs-CM,PVP could inhibit the viability of breast cancer SKBr-3 cells indirectly.Moreover,PVP reduced the mRNA expression (P<0.01) and protein secretion of bFGF (P<0.01) in CAFs.Conclusion:PVP could exert an anti-cancer effect on breast CAFs by inhibiting bFGF expression,thus inhibiting the growth of breast cancer SKBr-3 cells indirectly.
其他文献
Respected leaders, distinguished guests, venerable seniors and comrades, rnToday, the Meeting Commemorating the 50th Anniversary of Chairman MAO Ze-dong\'s Important Instructions on Western Medicine Doctors Learning Traditional Chinese Medicine was inau
期刊
Objective:To evaluate the effect of Chinese herbal medicine formula,modified Liujunzi Decoction(六君子汤,MLJZT),for anorexia,utilized as adjunct therapy during chemotherapy treatment for patients with advanced non-small cell lung cancer (NSCLC).Methods:The st
Objective: To assess the effect and safety of Hydroxysafflor Yellow A for Injection (HSYAI) in treating patients with acute ischemic stroke (AIS) and blood stasis syndrome (BSS).Methods: A multicenter,randomized,double-blind,multiple-dose,active-controlle
Objective: To evaluate the clinical efficacy and safety of Congrong Shujing Granules (苁蓉舒痉颗粒,CSGs) in treating patients with Parkinson\'s disease (PD) and Chinese medicine (CM) syndrome of Shen (Kidney) essence deficiency,and to investigate the potentia
Objective:To investigate the inhibitory effect of Linggui Zhugan Decoction (LZD,苓桂术甘汤)on the ventricular remodeling (VR) after acute myocardial infarction (AMI) and related mRNA and proteins expression in transforming growth factor-beta 1 (TGF-β1)/Smad si
Objective:To observe the intervention effects of Tiaobu Xinshen Recipe(调补心肾方,TXR) on patients with mild cognitive impairment caused by Alzheimer\'s disease (MCI-AD).Methods:Totally 88 MCI-AD patients with syndrome of Xin (Heart) and Shen (Kidney) defici
Primary Sj(o)gren\'s syndrome (pSS) is a chronic autoimmune disease with a long duration of illness,for which there is no cure.Patients often suffer from anxiety and depression due to various reasons,exhibiting a decline in their quality of life.Chinese
Objective: To investigate the therapeutic and synergistic effects of QHC (combination of quercetin (Q),hirudin (H) and cinnamaldehyd (C)) on Schwann cell differentiation and myelination against high glucose (HG) induced injury.Methods: Primary-culture Sch
Traditional glucose-lowering chemical agents,including various types of insulin and insulin secretagogues,insulin sensitizers,gliptins,etc.,are based on diabetic pathogenesis of insulin resistance (IR) and islet insufficiency.Numerous evidence-based medic
Objective:To evaluate whether low-frequency ultrasound-facilitated transdermal delivery of a Chinese medicine (CM) formula could improve the efficacy of intrapleural administration of interleukin-2 (IL-2)in treatment of malignant pleural effusion (MPE).Me